Jack Nielsen, Director at Harmony Biosciences Holdings, Inc. (HRMY), sold 31,627 shares at $50.10 ($1.6M) on 2022-03-18, disclosed to the SEC on 2022-03-21.
Open-market sale of $1.6M HRMY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.05 | 735 | $37K | 2.3% |
| 2 | $50.05 | 5,161 | $258K | 16.3% |
| 3 | $50.05 | 5,161 | $258K | 16.3% |
| 4 | $50.10 | 1,282 | $64K | 4.1% |
| 5 | $50.10 | 1,282 | $64K | 4.1% |
| 6 | $50.10 | 9,003 |
| $451K |
| 28.5% |
| 7 | $50.10 | 9,003 | $451K | 28.5% |
| Total | $50.08 avg | 31,627 | $1.6M | 100% |
| Filing → |
| HRMY | SELL | 2022-12-01 | $11.4M | — | Filing → |
| HRMY | SELL | 2022-11-22 | $7.7M | — | Filing → |
| HRMY | SELL | 2022-11-15 | $16.1M | — | Filing → |